A Public Health Approach to Hepatitis C in an Urban Setting

Overview

Journal Am J Public Health

Specialty Public Health

Date 2017 Apr 21

PMID 28426310

Citations 10

Authors

Fabienne Laraque

Jay K Varma

Affiliations

Soon will be listed here.

Abstract

The clinical consequences of HCV infection are increasing because the population with the highest prevalence of the infection, persons born between 1945 and 1965, is aging. As a result, health care expenditures are expected to increase. Now that a cure for HCV infection is the norm, a public health approach is necessary to identify, link to care, and treat infected persons and prevent new infections. We believe that the success of public health interventions, such as those for tuberculosis, can be translated to HCV infection. New York City has many HCV-infected residents and has developed a public health approach to controlling the HCV epidemic. It encompasses surveillance and monitoring, case finding, linkage to care, care coordination, increasing clinical provider capacity for screening and treatment, increasing public awareness, and primary prevention.

Citing Articles

Care Facilitation Advances Movement Along the Hepatitis C Care Continuum for Persons With Human Immunodeficiency Virus, Hepatitis C, and Substance Use: A Randomized Clinical Trial (CTN-0064).

Metsch L, Feaster D, Gooden L, Masson C, Perlman D, Jain M Open Forum Infect Dis. 2021; 8(8):ofab334.

PMID: 34377726 PMC: 8339611. DOI: 10.1093/ofid/ofab334.

A Digital Case-Finding Algorithm for Diagnosed but Untreated Hepatitis C: A Tool for Increasing Linkage to Treatment and Cure.

Wyatt B, Perumalswami P, Mageras A, Miller M, Harty A, Ma N Hepatology. 2021; 74(6):2974-2987.

PMID: 34333777 PMC: 9299620. DOI: 10.1002/hep.32086.

Changing Urban-Rural Disparities in the Utilization of Direct-Acting Antiviral Agents for Hepatitis C in U.S. Medicare Patients, 2014-2017.

Du P, Wang X, Kong L, Riley 3rd T, Jung J Am J Prev Med. 2020; 60(2):285-293.

PMID: 33221144 PMC: 7855597. DOI: 10.1016/j.amepre.2020.08.031.

Hepatitis C Antibody Screening Among Baby Boomers by a Community-Based Health Insurance Company.

Litaker J, Tamez N, Lopez Bray C, Allison R, Durkalski W, Taylor R Popul Health Manag. 2020; 24(4):492-495.

PMID: 33197366 PMC: 8403194. DOI: 10.1089/pop.2020.0214.

Hepatitis C incidence and prevalence among Puerto Rican people who use drugs in New York City.

Arasteh K, Des Jarlais D, Feelemyer J, McKnight C Glob Public Health. 2020; 15(12):1789-1799.

PMID: 32427534 PMC: 10204793. DOI: 10.1080/17441692.2020.1768276.

References

Taylor Z, Nolan C, Blumberg H . Controlling tuberculosis in the United States. Recommendations from the American Thoracic Society, CDC, and the Infectious Diseases Society of America. MMWR Recomm Rep. 2005; 54(RR-12):1-81. View

Chen S, Morgan T . The natural history of hepatitis C virus (HCV) infection. Int J Med Sci. 2006; 3(2):47-52. PMC: 1415841. DOI: 10.7150/ijms.3.47. View

van den Berg C, Smit C, van Brussel G, Coutinho R, Prins M . Full participation in harm reduction programmes is associated with decreased risk for human immunodeficiency virus and hepatitis C virus: evidence from the Amsterdam Cohort Studies among drug users. Addiction. 2007; 102(9):1454-62. PMC: 2040242. DOI: 10.1111/j.1360-0443.2007.01912.x. View

Kallman J, Arsalla A, Park V, Dhungel S, Bhatia P, Haddad D . Screening for hepatitis B, C and non-alcoholic fatty liver disease: a survey of community-based physicians. Aliment Pharmacol Ther. 2009; 29(9):1019-24. DOI: 10.1111/j.1365-2036.2009.03961.x. View

Napper L, Fisher D, Reynolds G, Johnson M . HIV risk behavior self-report reliability at different recall periods. AIDS Behav. 2009; 14(1):152-61. PMC: 2814040. DOI: 10.1007/s10461-009-9575-5. View

Basseri B, Yamini D, Chee G, Enayati P, Tran T, Poordad F . Comorbidities associated with the increasing burden of hepatitis C infection. Liver Int. 2010; 30(7):1012-8. DOI: 10.1111/j.1478-3231.2010.02235.x. View

Southern W, Drainoni M, Smith B, Christiansen C, McKee D, Gifford A . Hepatitis C testing practices and prevalence in a high-risk urban ambulatory care setting. J Viral Hepat. 2010; 18(7):474-81. PMC: 2990787. DOI: 10.1111/j.1365-2893.2010.01327.x. View

Williams I, Bell B, Kuhnert W, Alter M . Incidence and transmission patterns of acute hepatitis C in the United States, 1982-2006. Arch Intern Med. 2011; 171(3):242-8. DOI: 10.1001/archinternmed.2010.511. View

Roblin D, Smith B, Weinbaum C, Sabin M . HCV screening practices and prevalence in an MCO, 2000-2007. Am J Manag Care. 2011; 17(8):548-55. View

10.

Grebely J, Dore G . What is killing people with hepatitis C virus infection?. Semin Liver Dis. 2011; 31(4):331-9. DOI: 10.1055/s-0031-1297922. View

11.

Denniston M, Klevens R, McQuillan G, Jiles R . Awareness of infection, knowledge of hepatitis C, and medical follow-up among individuals testing positive for hepatitis C: National Health and Nutrition Examination Survey 2001-2008. Hepatology. 2012; 55(6):1652-61. PMC: 4586034. DOI: 10.1002/hep.25556. View

12.

Smith B, Morgan R, Beckett G, Falck-Ytter Y, Holtzman D, Teo C . Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945-1965. MMWR Recomm Rep. 2012; 61(RR-4):1-32. View

13.

Fafi-Kremer S, Fauvelle C, Felmlee D, Zeisel M, Lepiller Q, Fofana I . Neutralizing antibodies and pathogenesis of hepatitis C virus infection. Viruses. 2012; 4(10):2016-30. PMC: 3497039. DOI: 10.3390/v4102016. View

14.

van der Meer A, Veldt B, Feld J, Wedemeyer H, Dufour J, Lammert F . Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis. JAMA. 2012; 308(24):2584-93. DOI: 10.1001/jama.2012.144878. View

15.

Razavi H, Elkhoury A, Elbasha E, Estes C, Pasini K, Poynard T . Chronic hepatitis C virus (HCV) disease burden and cost in the United States. Hepatology. 2013; 57(6):2164-70. PMC: 3763475. DOI: 10.1002/hep.26218. View

16.

Ward J . The hidden epidemic of hepatitis C virus infection in the United States: occult transmission and burden of disease. Top Antivir Med. 2013; 21(1):15-9. PMC: 6148892. View

17.

Balter S, Stark J, Kennedy J, Bornschlegel K, Konty K . Estimating the prevalence of hepatitis C infection in New York City using surveillance data. Epidemiol Infect. 2013; 142(2):262-9. PMC: 3891473. DOI: 10.1017/S0950268813000952. View

18.

Manos M, Darbinian J, Rubin J, Ray G, Shvachko V, Denis B . The effect of hepatitis C treatment response on medical costs: a longitudinal analysis in an integrated care setting. J Manag Care Pharm. 2013; 19(6):438-47. PMC: 10438335. DOI: 10.18553/jmcp.2013.19.6.438. View

19.

Masson C, Delucchi K, McKnight C, Hettema J, Khalili M, Min A . A randomized trial of a hepatitis care coordination model in methadone maintenance treatment. Am J Public Health. 2013; 103(10):e81-8. PMC: 3853128. DOI: 10.2105/AJPH.2013.301458. View

20.

Denniston M, Jiles R, Drobeniuc J, Klevens R, Ward J, McQuillan G . Chronic hepatitis C virus infection in the United States, National Health and Nutrition Examination Survey 2003 to 2010. Ann Intern Med. 2014; 160(5):293-300. PMC: 4562398. DOI: 10.7326/M13-1133. View